Sepsivac receives Philippines FDA’s approval for COVID treatment

Cadila pharmaceutical’s Sepsivac received first overseas approval after the Philippine's Food and Drug Administration (FDA) approved the drug for COVID-19 treatment in the country.

The country also allowed special importation of the drug as the country is witnessing rapid rise in COVID related ailments and desperately tries to strengthen its fight against the virus.
If severe, COVID 19 has been associated with multiple ailments including respiratory complications, cytokine storm, and sepsis amongst others which can have many long lasting side effects. Cadila Pharmaceuticals’s Sepsivac can help in improving the health of a person affected with Covid and can effectively reduce the negative side effects of the virus.

Philippines reported a daily record high for COVID-19 cases it is experiencing a third surge that began early August, on Aug 28 reported a record high of more than 19,000 cases.